Skip to main content
SpringerLink
Log in
Book cover

Sepsis pp 90–100Cite as

AIDS in the Intensive Care Unit

  • Chapter

  • 126 Accesses

Summary

Patients infected with the human immunodeficiency virus (HIV) are at risk of acquiring a great variety of critical illnesses because of progressive immunodeficiency and the multiple exposures to medications they are receiving. Notwithstanding the great availability of prophylactic effective treatments, Pneumocystis carinii (recently called Pneumocystis jiroveci) continues to be an important cause for pneumonia and respiratory failure, requiring admission to the ICU with a significant risk of increased mortality. Bacterial sepsis is another reason for managing this group of patients at the ICU. This imposes a challenge for critical care personnel because of the worse prognosis observed in this population. On the other hand, the effective use of combined antiretroviral therapy [highly active antiretroviral therapy (HAART)] has reduced the high incidence of opportunistic infections and has drastically improved long-term survival in patients infected with HIV.2 Nevertheless, the use of these agents could be associated with severe adverse effects (e.g., pancreatitis, hepatic steatosis, and lactic acidosis syndrome), which in a great many cases require management in the ICU.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Nickas G, Wachter RM. Outcomes of intensive care for patients with human immunodeficiency virus infection. Arch Intern Med 2000; 160: 541–7.

    Article  PubMed  CAS  Google Scholar 

  2. Bartlett JG, Gallant JE. Antiretroviral therapy. In: Bartlett JG, Gallant JE, eds. 2001–2002 Medical management of HIV infection. Baltimore: Johns Hopkins University, Division of Infectious Diseases, 2001: 39–97.

    Google Scholar 

  3. De Palo VA, Millstein BH, Mayo PH, et al. Outcome of intensive care in patients with HIV infection. Chest 1995; 107: 506–10.

    Article  PubMed  Google Scholar 

  4. Lazard T, Retel O, Guidet B, et al. AIDS in a medical intensive care unit: immediate prognosis and long-term survival. JAMA 1996; 276: 1240–5.

    Article  PubMed  CAS  Google Scholar 

  5. Rosen MJ, Clayton K, Schneider RF, et al. Intensive care of patients with HIV infection: Utilization, critical illnesses, and outcomes. Am J Respir Crit Care Med 1997; 155: 67–71.

    PubMed  CAS  Google Scholar 

  6. Casalino E, Mendoza-Sassi G, Wolff M, et al. Predictors of short and long-term survival in HIV-infected patients admitted to the ICU. Chest 1998; 113: 421–9.

    Article  PubMed  CAS  Google Scholar 

  7. Bonarek M, Morlat P, Chene G, et al. Prognostic score of short-term survival in HIV-infected patients admitted to medical intensive care units. Int J STD AIDS 2001; 12: 239–44.

    Article  PubMed  CAS  Google Scholar 

  8. Rosen MJ. Intensive care of patients with HIV infection. Semin Respir Infect 1999; 14: 366–71.

    PubMed  CAS  Google Scholar 

  9. Leifeld L, Rockstroh J, Skaide S, et al. Indication, outcome and follow-up of intensive care in patients with HIV-infection. Eur J Med Res 2000; 5: 199–202.

    PubMed  CAS  Google Scholar 

  10. Reddy R, Daftary M. Predictors of outcomes in HIV-positive ICU patients. IDSA, Chicago, IL, 2002, abstract 537.

    Google Scholar 

  11. Curtis JR. ICU outcomes for patients with HIV infection: a moving target. Chest 1998; 113: 269–70.

    Article  PubMed  CAS  Google Scholar 

  12. Morris A, Wachter RM, Luce J, et al. Improved survival with highly active antiretroviral therapy in HIV-infected patients with severe Pneumocystis carinii pneumonia. AIDS 2003; 17: 73–80.

    Article  PubMed  Google Scholar 

  13. Morris A, Creasman J, Turner J, et al. Intensive care of human immunodeficiency virus-infected patients during the era of highly active antiretroviral therapy. Am J Respir Crit Care Med 2002; 166: 262–7.

    Article  PubMed  Google Scholar 

  14. Reddy R, Daftary M. Outcomes of using antiretrovirals in critically ill HIV infected patients in the ICU setting. IDSA, Chicago, IL, 2002, abstract 539.

    Google Scholar 

  15. Meyer CN, Skinhoj P, Prag J. Bacteremia in HIV positive and AIDS patients: incidence, species distribution, risk-factors, outcome, and influence of long-term prophylactic antibiotic treatment. Scand J Infect Dis 1994; 26: 635–42.

    Article  PubMed  CAS  Google Scholar 

  16. Northfelt DW, Polsky B. Bacteremia in persons with HIV infection. AIDS Clin Rev 1991; 59–79.

    Google Scholar 

  17. Brettle RP. Bacterial infections in HIV: the extent and nature of the problem. Int J STD AIDS 1997; 8: 5–15.

    Article  PubMed  CAS  Google Scholar 

  18. Rosenberg AL, Seneff MG, Atiyeh L, et al. The importance of bacterial sepsis in intensive care unit patients with acquired immunodeficiency syndrome: Implications for future care in the age of increasing antiretroviral resistance. Crit Care Med 2001; 29: 548–56.

    Article  PubMed  CAS  Google Scholar 

  19. Manfredi R, Nanetti A, Ferri M, et al. HIV associated non-mycobacterial sepsisbacteremia, before and during the highly active antiretoviral therapy era. AIDS 1999; 13: 1274–6.

    Article  PubMed  CAS  Google Scholar 

  20. Thyrault M, Gachot B, Chastang C, et al. Septic shock in patients with the acquired immunodeficiency syndrome. Intensive Care Med 1997; 23: 1018–23.

    Article  PubMed  CAS  Google Scholar 

  21. Vidal F, Mensa J, Maritnex JA, et al. Pseudomonas aeruginosa bacteremia in patients infected with human immunodeficiency virus type 1. Eur J Clin Microbiol Infect Dis 1999; 18: 473–7.

    Article  PubMed  CAS  Google Scholar 

  22. Da Silva B, Singer W, Fong IW, et al. In vivo cytokine and neuroendocrine responses to endotoxin in human immunodeficiency virus-infected subjects. J Infect Dis 1999; 180: 106–15.

    Article  PubMed  CAS  Google Scholar 

  23. DiPiro JT. Cytokibe networks with infection: microbacterial infections, leishmaniasis, human immunodeficiency virus infection, and sepsis. Pharmacotherapy 1997; 17: 205–23.

    PubMed  CAS  Google Scholar 

  24. Spellberg B, Edwards JE. Type 1/type 2 immunity in infectious diseases. Clin Infect Dis 2001; 32: 76–102.

    Article  PubMed  CAS  Google Scholar 

  25. Schliep TC, Yarrish RL. Pneumocystis carinii pneumonia. Semin Respir Infect 1999; 14: 333–43.

    PubMed  CAS  Google Scholar 

  26. Mansharamani NG, Garland R, Delaney D, et al. Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995: Comparison of HIV-associated cases to other immunocompromised states. Chest 2000; 118: 704–11.

    Article  PubMed  CAS  Google Scholar 

  27. Bedos JP, Dumoulin JL, Gachot B, et al. Pneumocystis carinii pneumonia requiring intensive care management: survival and prognostic study in 110 patients with human immunodeficiency virus. Crit Care Med 1999; 27: 1109–15.

    Article  PubMed  CAS  Google Scholar 

  28. Confalonieri M, Calderini E, Terraciano S, et al. Noninvasive ventilation for treating acute respiratory failure in AIDS patients with Pneumocystis carinii pneumonia. Intensive Care Med 2002; 28: 1233–8.

    Article  PubMed  Google Scholar 

  29. Kumar SD, Krieger BP. CD4 lymphocyte counts and mortality in AIDS patients requiring mechanical ventilator support due to Pneumocystis carinii pneumonia. Chest 1998; 113: 430–3.

    Article  PubMed  CAS  Google Scholar 

  30. Schneider RF. Bacterial pneumonia. Semin Respir Infect 1999; 14: 327–32.

    PubMed  CAS  Google Scholar 

  31. Brodt HR, Kamps BS, Gute P, et al. Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy. AIDS 1997; 11: 1731–8.

    Article  PubMed  CAS  Google Scholar 

  32. Afessa B, Green B. Bacterial pneumonia in hospitalized patients with HIV infection: the Pulmonary Complications, ICU Support, and Prognostic Factors of Hospitalized Patients with HIV (PIP) Study. Chest 2000; 117: 1017–22.

    Article  PubMed  CAS  Google Scholar 

  33. Schneider RF, Rosen MJ. Pneumococcal infections in HIV-infected adults. Semin Respir Infect 1999; 14: 237–42.

    PubMed  CAS  Google Scholar 

  34. Harwell J, Brown RB. The drug-resistant pneumococcus: clinical relevance, therapy, and prevention. Chest 2000; 117: 530–41.

    Article  PubMed  CAS  Google Scholar 

  35. Hoban DJ, Doern GV, Fluit AC, et al. Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in the SENTRY antimicrobial surveillance program. Clin Infect Dis 2001; 32: S81–93.

    Article  PubMed  CAS  Google Scholar 

  36. Meynard JL, Barbut F, Blum L, et al. Risk factors for isolation of Streptococcus pneumoniae with decreased susceptibility to penicillin G from patients infected with human immunodeficiency virus. Clin Infect Dis 1996; 22: 437–40.

    Article  PubMed  CAS  Google Scholar 

  37. Feldman C, Glatthaar M, Morar R, et al. Bacteremic pneumococcal pneumonia in HIV seropositive and HIV seronegative adults. Chest 1999; 116: 107–14.

    Article  PubMed  CAS  Google Scholar 

  38. Turett GS, Blum S, Fazal BA, et al. Penicillin resistance and other predictors of mortality in pneumococcal bacteremia in population with high human immunodeficiency virus seroprevalence. Clin Infect Dis 1999; 29: 321–7.

    Article  PubMed  CAS  Google Scholar 

  39. Zahar JR, Azoulay E, Klement E, et al. Delayed treatment contributes to mortality in ICU patients with severe active pulmonary tuberculosis and acute respiratory failure. Intensive Care Med 2001; 27: 513–20.

    Article  PubMed  CAS  Google Scholar 

  40. Acosta BS, Grimsley EW. Zidovudine-associated type B lactic acidosis and hepatic steatosis in an HIV-infected patient. South Med J 1999; 92: 421–3.

    Article  PubMed  CAS  Google Scholar 

  41. Boswell DE, Styrt BA. Lactic acidosis in patients receiving nucleoside reverse transcriptase inhibitors abstract 1284 ]. In Abstracts of the 39`h Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, 1999: 496.

    Google Scholar 

  42. Sundar K, Saurez M, Banogon PE, et al. Zidovudine-induced fatal lactic acidosis and hepatic failure in patients with acquired immunodeficiency syndrome: report of two patients and review of the literature. Crit Care Med 1997; 25: 1425–30.

    Article  PubMed  CAS  Google Scholar 

  43. Mokrycki MH, Harris C, May H, et al. Lactic acidosis associated with stavudine administration: a report of live cases. Clin Infect Dis 2000; 30: 198–200.

    Article  Google Scholar 

  44. Brinkman K, Ter Hofstede HJM, Burger DM, et al. Adverse effects of reverse transcriptase inhibitors: Mitochondrial toxicity as common pathway. AIDS 1998; 12: 1735–44.

    Article  PubMed  CAS  Google Scholar 

  45. Cortez KJ, Cotterio RA, Mileno MD, et al. Non-fatal nucleoside analogue-associated lactic acidosis in three HIV-infected patients [abstract 212]. In Program and Abstracts of the 37`h Annual Meeting of the Infectious Disease Society of America, Philadelphia, 1999: 76.

    Google Scholar 

  46. Luzzati R, Del Bravo P, Di Perrie G, et al. Riboflavin and severe lactic acidosis [letter]. Lancet 1999; 353: 901–2.

    Article  PubMed  CAS  Google Scholar 

  47. Fouty B, Frerman F, Reyes R. Riboflavin to treat nucleoside analogue induced lactic acidosis [letter]. Lancet 1998; 352: 291–2.

    Article  PubMed  CAS  Google Scholar 

  48. Chodock R, Mylonakis E, Shemin D, et al. Survival of a human immunodeficiency patient with nucleoside-induced lactic acidosis: Role of hemodialysis treatment. Nephrol Dial Transplant 1999; 14: 2484–6.

    Article  PubMed  CAS  Google Scholar 

  49. Lenzo NP, Garas BA, French MA. Hepatic steatosis and lactic acidosis associated with stavudine treatment in a HIV patient: A case report. AIDS 1997; 11: 1294–6.

    CAS  Google Scholar 

  50. Schramm C, Wanitschke R, Galle PR. Thiamine for the treatment of nucleoside analogue-induced severe lactic acidosis. Eur J Anaesthesiol 1999; 16: 733–5.

    PubMed  CAS  Google Scholar 

  51. Dutta SK, Ting CD, Lai LL. Study of prevalence, severity and etiological factors associated with acute pancreatitis in patients infected with human imunodeficiency virus. Am J Gastroenterol 1997; 92: 2044–8.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Guillermo Ortiz-Ruiz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carlos Alvarez
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Universidad del Bosque, Bogotá, Colombia

    Guillermo Ortiz-Ruiz MD (Professor of Pulmonary and Critical Care Medicine) (Professor of Pulmonary and Critical Care Medicine)

  2. Fundacion Clinica Shaio, Bogotá, Colombia

    Marco A. Perafán MD (Professor of Cardiology and Critical Care Medicine) (Professor of Cardiology and Critical Care Medicine)

  3. Department of Surgery, Klinikum Grosshadern, University of Munich, Munich, Germany

    Eugen Faist MD (Professor) (Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer Science+Business Media New York

About this chapter

Cite this chapter

Ortiz-Ruiz, G., Alvarez, C. (2004). AIDS in the Intensive Care Unit. In: Ortiz-Ruiz, G., Perafán, M.A., Faist, E. (eds) Sepsis. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-3824-7_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-3824-7_8

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-20451-2

  • Online ISBN: 978-1-4757-3824-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation